Feedback

European Commission not to extend contracts with AstraZeneca, Johnson & Johnson companies

Source : 112 Ukraine

Brussels intends to focus on Pfizer and Moderna vaccines
12:50, 14 April 2021

Open source

The European Commission will not extend contracts with the AstraZeneca and Johnson & Johnson companies that produce vaccines against coronavirus as Reuters reported.

It is noted that the European Commission in agreement with the EU leaders made a decision that the contracts with the companies that produce vaccines that act in 2021 will not be extended after their expiry.

Related: US to suspend use of Johnson & Johnson vaccine, - media

Meanwhile, Brussels intends to focus on Pfizer and Moderna vaccines.

Besides, the official EU representative stated that the European Commission demands explanations from J&J Company on an ‘unexpected’ delay in drug supplies to the EU.

On April 6, the EMA representative confirmed there is a connection between the AstraZeneca vaccine against coronavirus and the development of blood clots in the patients' bodies.

Related: Connection between Johnson&Johnson vaccine and blood clots not confirmed yet, - EMA

The first messages about side effects after vaccination with AstraZeneca (Vaxzevria) appeared in early March. Austria was the first to state it suspends the vaccination with the use of this drug. Later, more than 20 countries did the same.

Currently, the lethal cases after the AstraZeneca drug were reported by the UK, Norway, Georgia, Germany and other countries.

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more